Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

New Housing Options Emerge for Older Americans

by Team Lumida
October 20, 2025
in Health and Longevity
Reading Time: 4 mins read
A A
0
New Housing Options Emerge for Older Americans
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • Older Americans are increasingly adopting alternative living models—house-sharing with unrelated roommates, multigenerational homes, and cohousing—to balance affordability, companionship, and care needs.
  • House-sharing among 50+ adults has doubled over two decades to ~990,000 (2023), aided by matching nonprofits that de-risk arrangements with background checks and agreements.
  • Builders are scaling multigenerational floor plans (e.g., Lennar’s Next Gen) with separate suites, as aging-in-place demand meets high housing costs and rising care needs.
  • Cohousing communities—self-governed, small-scale neighborhoods with shared amenities—are gaining traction in high-cost regions; ~150 exist in North America, many age-focused.

What happened?

Americans 65+ are set to represent roughly 20% of the population by 2030, and many prefer to age in place. Rising housing and care costs, travel patterns, and the desire for companionship are pushing experimentation beyond traditional single-family homes or senior facilities. The article profiles multiple models: peers co-purchasing homes and adding a renter for oversight; nonprofit matching services (HomeShare Oregon, Sunshine Home Share) facilitating compatible housemates; multigenerational designs that integrate independent suites under one roof; and resident-led cohousing that shares maintenance, gardens, and common areas through consensus governance. These options address practical needs—cost, safety, social connection, and light caregiving—without full institutional settings.

Why it matters

Demographics and affordability are reshaping senior housing demand: as the 65+ cohort approaches one in five Americans by 2030, many seek to age in place but face rising housing and care costs, social isolation, and safety concerns. Alternative models—house-sharing, multigenerational designs, and cohousing—can delay or reduce moves into higher-acuity (and higher-cost) facilities by providing companionship, light oversight, and cost-sharing, which in turn may ease pressure on public programs and families. For investors, this pivot supports durable demand for builder product lines with integrated suites/ADUs and accessibility features, retrofit and smart-home services that enable safe independence, and platform-enabled matching that unlocks underutilized bedrooms as quasi-supply. It also signals opportunity for insurers, lenders, and REITs to design products around co-ownership, retrofit financing, and community-scale amenities, while municipalities that streamline ADU zoning can expand local housing capacity without large greenfield builds.

What’s next

Expect faster adoption of multigenerational floor plans and ADU-friendly zoning, growth in vetted house-share platforms with standardized contracts and insurance, and expanded financing solutions for co-buying and retrofits that de-risk shared arrangements. Cohousing replication will likely accelerate via developer partnerships and playbooks that compress permitting and consensus-building timelines. Key indicators to watch include the share of new-home starts with “Next Gen”-style suites, ADU permit volumes, throughput at nonprofit and private matching platforms, and lender/insurer participation in co-ownership and in-home care bundles. Execution risks—compatibility, HOA and legal barriers, privacy and safety—will require clear governance frameworks and light-touch regulation; jurisdictions and companies that solve these frictions earliest are positioned to capture outsized demand from the aging-in-place market.

Source
Previous Post

How China Took Over the World’s Rare-Earths Industry

Next Post

Apple’s New iPhone Outsells Previous Model by 14% in US, China

Recommended For You

The FDA Is Fast-Tracking Psychedelics. The Infrastructure to Support Them Isn’t Ready.

by Team Lumida
7 hours ago
Abstract colorful psychedelic swirling patterns

Trump's executive order to accelerate psychedelic drug development is welcome — but Bloomberg Opinion's Lisa Jarvis warns the ketamine clinic free-for-all is a cautionary tale the FDA must...

Read more

Ultrasound on a Chip: Butterfly Network’s $4,000 Device Is Taking Medical Imaging Global

by Team Lumida
3 days ago
a person holding a tablet

Butterfly Network's semiconductor-based handheld ultrasound costs a fraction of traditional machines and has reached 150,000 deployments worldwide, pairing AI with imaging to put diagnostics in the hands of...

Read more

Nearly 1 in 8 Americans Now Uses Sleep Aids — and Pharma Is Taking Notice

by Team Lumida
5 days ago
woman sleeping on bed under blankets

A new federal study finds 13% of U.S. adults rely on prescription drugs, OTC supplements, marijuana, or CBD to sleep, as Eli Lilly's $7.8B acquisition of a sleep...

Read more

Amazon One Medical Launches GLP-1 Weight Loss Program at $25 a Month

by Team Lumida
6 days ago
Amazon Targets Rural America: A Game-Changer for Delivery Services

Amazon One Medical is rolling out a weight management program that includes GLP-1 medications, offering compounded pills starting at $25/month with same-day delivery in 3,000 cities.

Read more

Melatonin: What Mayo Clinic Says About Its Side Effects, Safety, and Best Uses

by Team Lumida
3 weeks ago
Melatonin: What Mayo Clinic Says About Its Side Effects, Safety, and Best Uses

Melatonin is generally safe for short-term use and non-habit-forming, but it carries real side effects and drug interactions that most users overlook — Mayo Clinic breaks down what...

Read more

How Much Muscle Should You Have — and What Happens When You Lose It?

by Team Lumida
3 weeks ago
diagram

Muscle mass averages, why they matter for long-term health, and what the science says about measuring and building skeletal muscle across every age group.

Read more

AI Scribes Save Clinicians 13–16 Minutes a Day — and Boost Visit Volume by 1.7%, Study Finds

by Team Lumida
3 weeks ago
AI Investment Boom: How Tech Giants Are Leading the Charge

The largest study of AI scribe adoption to date — 8,500+ clinicians across five academic medical centers — found the tools cut EHR time by 3% and documentation...

Read more

America’s Fertility Rate Just Hit a Record Low — and the Numbers Are Getting Harder to Ignore

by Team Lumida
3 weeks ago
America’s Fertility Rate Just Hit a Record Low — and the Numbers Are Getting Harder to Ignore

The U.S. general fertility rate fell to 53.1 births per 1,000 women in 2025 — a record low — while the total fertility rate dropped to 1.57, well...

Read more

Healthcare Roundup: Medicare Advantage Gets a $13B Boost, Drug Tariffs Hit 100%, and Wegovy Goes Discount

by Team Lumida
4 weeks ago
person sitting while using laptop computer and green stethoscope near

A packed week in healthcare: Medicare Advantage rates came in at a better-than-expected 2.48% increase, Trump unveiled 100% tariffs on some brand-name drugs, Gilead and Neurocrine spent $8B...

Read more

Why Americans Pay More for Healthcare Than Anyone Else in the World

by Team Lumida
4 weeks ago
doctor holding red stethoscope

A new WSJ analysis breaks down the structural forces behind America's sky-high healthcare costs — from monopoly hospitals and unregulated drug prices to administrative bloat and physician salaries...

Read more
Next Post
Why Apple’s AI Approach May Save Its Reputation

Apple’s New iPhone Outsells Previous Model by 14% in US, China

Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Crypto Miners Riding the AI Wave Are Leaving Bitcoin Behind

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

silver and diamond ring on white table

Cadillac’s Iconic Escalade Goes Electric With the Launch of the $127,700 Escalade IQ

April 14, 2025
Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Trump’s Stablecoin Push Accelerates Crypto Regulation in Asia

August 2, 2025
turned on flat screen monitor

Markets Stabilize as China’s Measured Tariff Response Eases Trade War Fears

February 4, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018